We’re pleased to announce the appointment of Graham Morris as President of the Europe 5 (France, Germany, Italy, Spain, and the United Kingdom) effective 1st November 2018.
Graham joins STEM from Bristol-Myers Squibb where he held several senior commercial leadership roles including Worldwide Oncology Lead (Europe and Emerging markets), Strategy and Operations Lead (Emerging markets), EMEA Brand Lead roles, and UK Business Unit Director (primary care). Prior to BMS, Graham was at AstraZeneca UK, Sanofi UK, and Dupont Pharma UK.
As President of the EU5, Graham will be responsible for developing and delivering STEM’s business across the larger EU markets.
Commenting on his new role, Graham said, “I’m delighted to be joining STEM at such an exciting time. Over several years STEM has built a strong reputation in the market, working with almost every Pharma company to help enhance their performance at a time when the industry is becoming ever more complex and competitive. STEM has achieved this due to the quality of its people and the unique services it provides. I’m very excited to be leading the next phase of STEM’s growth across the EU5.”
STEM CEO Jason McKenna said, “I’m excited to welcome Graham to STEM. He brings a wealth of EU and global experience that will be extremely valuable as we continue to grow our EU5 business under his leadership.”
Graham will also be a member of the STEM Board.